QSS
NBIX icon

Quantitative Systematic Strategies’s Neurocrine Biosciences NBIX Stock Holding History

Quantitative Systematic Strategies’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,567
Closed -$313K – 676
2020
Q2 		$313K Buy
+2,567
New +$284K 0.06% 403
2019
Q4 		– Sell
-4,699
Closed -$423K – 611
2019
Q3 		$423K Buy
4,699
+2,057
+78% +$192K 0.1% 263
2019
Q2 		$223K Buy
+2,642
New +$217K 0.04% 392
2017
Q4 		– Sell
-4,983
Closed -$305K – 620
2017
Q3 		$305K Buy
+4,983
New +$263K 0.08% 331
2017
Q2 		– Sell
-6,017
Closed -$261K – 490
2017
Q1 		$261K Buy
+6,017
New +$258K 0.07% 283
2016
Q3 		– Sell
-7,077
Closed -$321K – 450
2016
Q2 		$321K Buy
+7,077
New +$326K 0.15% 205
2016
Q1 		– Sell
-5,641
Closed -$319K – 639
2015
Q4 		$319K Buy
+5,641
New +$287K 0.09% 317

Other funds holding NBIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return